PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: leadership
Merck and Novartis Down in Q3 Financial Reports
By Jennifer Markarian
Pharmaceutical industry leaders Novartis and Merck—among others—released second-quarter 2012 results showing global sales down in third-quarter 2012, with growth in key pharmaceutical products helping to offset losses due to patent expirations.
Also posted in Deals, Global, Guest Blog Tagged Big Pharma, financial reports, Merck, Novartis, Q3 Leave a comment
Obamacare After Nov 6th: Trouble for Pharma?
by Tom Norton
No doubt the November 6th election is going to be close, very close: close for the Presidency, close for the Senate, and possibly close for the House. So close, in fact, it’s possible that no substantial political change will occur in Washington, as a result.
That said, for the U.S. pharmaceutical industry this is [...]
Also posted in Events, FDA, Legal, Market Access, R&D, Regulatory, pricing Tagged ACOs, CER, IPAB, Obamacare, PCORI 3 Comments
Ethics in Drug Innovation: The First Hurdle is Trust
By Ansis Helmanis
Ethics is a matter of trust, which in the regulatory space requires transparency and openness among all stakeholders, including patients and industry. This was the consensus of FDA Commissioner Margaret Hamburg and European Medicines Agency (EMA) Executive Director Guido Rasi, both of whom shared the podium with Nobel Laureate Professor Elie Wiesel [...]
Also posted in Europe, Events, FDA, Global, Guest Blog, Market Access, Patient Communication, Regulatory, healthcare, pricing Tagged CMS, Elie Wiesel, EMA, FDA, Guido Rasi, Margaret Hamburg, Prix Galien, reimbursement, sequestration Leave a comment
As American as Acid Reflux
Over the counter drug advertising is less regulated than prescription drug marketing, and selling directly to consumers comes with the benefit of bypassing an expert middleman: your doctor. But companies should still promote with caution.
Also posted in Advertising, Corporate Responsibility, E-Media, FDA, Market Access, Marketing, Regulatory, Strategy, healthcare, patient education Tagged Agency, celebrity, Consumer Advertising, Marketing and Advertising, OTC, Publicis 1 Comment
Pharma in the Dell: Working with Academia